Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
· cnbc.com
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuste...